Description |
Product Type |
Product Size |
Tablet |
14'S |
Product Company |
GSK |
Cefuroxime 250mg |
Product Type |
Product Size |
Tablets
|
12'S |
Product Company |
Sami Pharmaceutical |
Linezolid 600mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Sami Pharmaceutical |
Ceftriaxone Sodium |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Bosch Pharmaceuticals |
|
Product Type |
Product Size |
Tablet |
6'S |
Product Company |
GSK |
Co- amoxiclav 625mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Content | Cefuroxime is used to treat certain infections caused by bacteria, such as bronchitis(infection of the airway tubes leading to the lungs); gonorrhea (a sexually transmitted disease); Lyme disease (an infection that may develop after a person is bitten by a tick); and infections of the skin, ears, sinuses, throat, tonsils,, and urinary tract. Cefuroxime is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria. | Linezolid is used to treat infections, including pneumonia, and infections of the skin . Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria.
| Ceftriaxone is an antibiotic in the form of an injection that a healthcare provider gives you in a hospital or clinic. It treats bacterial infections. | Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. | Amoxicillin/clavulanic acid, also known as co-amoxiclav or amox-clav, sold under the brand name Augmentin, among others, is an antibiotic medication used for the treatment of a number of bacterial infections. | Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. |
Reviews
There are no reviews yet.